1975 - 1992年英格兰和威尔士原发性肝癌死亡率趋势：口服避孕药的影响
Trends in mortality from primary liver cancer in England and Wales 1975-92: influence of oral contraceptives.
作者信息
Mant J W, Vessey M P
机构信息
Department of Public Health and Primary Care, University of Oxford, Radcliffe Infirmary, UK.
出版信息
Br J Cancer. 1995 Sep;72(3):800-3. doi: 10.1038/bjc.1995.415.
Abstract
Numerous case-control studies have suggested a link between the oral contraceptive pill and liver cancer. The secular trends in liver cancer mortality rates for England and Wales from 1975 to 1992 were examined to determine whether an effect of the pill was apparent. Liver cancer mortality has remained constant in women in the age groups that have had major exposure to the pill.
摘要
众多病例对照研究表明口服避孕药与肝癌之间存在联系。对1975年至1992年英格兰和威尔士肝癌死亡率的长期趋势进行了研究，以确定避孕药的影响是否明显。在大量接触过避孕药的年龄组女性中，肝癌死亡率一直保持稳定。
相似文献
1
Trends in mortality from primary liver cancer in England and Wales 1975-92: influence of oral contraceptives.1975 - 1992年英格兰和威尔士原发性肝癌死亡率趋势：口服避孕药的影响
Br J Cancer. 1995 Sep;72(3):800-3. doi: 10.1038/bjc.1995.415.
2
Trends in mortality from carcinoma of the liver and the use of oral contraceptives.肝癌死亡率趋势与口服避孕药的使用情况
Br J Cancer. 1983 Sep;48(3):349-54. doi: 10.1038/bjc.1983.199.
3
Incidence and mortality of primary liver cancer in England and Wales: changing patterns and ethnic variations.英格兰和威尔士原发性肝癌的发病率与死亡率：变化趋势及种族差异
World J Gastroenterol. 2014 Feb 14;20(6):1544-53. doi: 10.3748/wjg.v20.i6.1544.
4
Recent trends in incidence of and mortality from breast, ovarian and endometrial cancers in England and Wales and their relation to changing fertility and oral contraceptive use.英格兰和威尔士乳腺癌、卵巢癌及子宫内膜癌的发病率和死亡率近期趋势及其与生育变化和口服避孕药使用的关系。
Br J Cancer. 1995 Aug;72(2):485-92. doi: 10.1038/bjc.1995.360.
5
Epidemiology of hepatocellular adenoma. The role of oral contraceptive use.肝细胞腺瘤的流行病学。口服避孕药的作用。
JAMA. 1979 Aug 17;242(7):644-8.
6
Mortality of hepatitis B surface antigen-positive blood donors in England and Wales.英格兰和威尔士乙肝表面抗原阳性献血者的死亡率。
Int J Epidemiol. 2003 Feb;32(1):118-24. doi: 10.1093/ije/dyg039.
7
Alcohol-related and hepatocellular cancer deaths by country of birth in England and Wales: analysis of mortality and census data.按出生国划分的英格兰和威尔士与酒精相关的肝细胞癌死亡情况：死亡率和人口普查数据分析
J Public Health (Oxf). 2009 Jun;31(2):250-7. doi: 10.1093/pubmed/fdp014. Epub 2009 Mar 18.
8
Cancer of the liver and the use of oral contraceptives.肝癌与口服避孕药的使用
Br Med J (Clin Res Ed). 1986 May 24;292(6532):1357-61. doi: 10.1136/bmj.292.6532.1357.
9
Female hormone utilisation and risk of hepatocellular carcinoma.女性激素的使用与肝细胞癌风险
Br J Cancer. 1993 Mar;67(3):635-7. doi: 10.1038/bjc.1993.116.
10
Fatal stroke and use of oral contraceptives: findings from a case-control study.致命性中风与口服避孕药的使用：一项病例对照研究的结果
Am J Epidemiol. 1992 Jul 1;136(1):35-45. doi: 10.1093/oxfordjournals.aje.a116418.
引用本文的文献
1
Impact of sex on the survival of patients with hepatocellular carcinoma: a Surveillance, Epidemiology, and End Results analysis.性别对肝癌患者生存的影响：监测、流行病学和最终结果分析。
Cancer. 2014 Dec 1;120(23):3707-16. doi: 10.1002/cncr.28912. Epub 2014 Jul 31.
2
Expression of lysosome-associated protein transmembrane 4B-35 in cancer and its correlation with the differentiation status of hepatocellular carcinoma.溶酶体相关蛋白跨膜4B-35在癌症中的表达及其与肝细胞癌分化状态的相关性。
World J Gastroenterol. 2005 May 14;11(18):2704-8. doi: 10.3748/wjg.v11.i18.2704.
3
Oral contraceptives and cancer. A review of the evidence.口服避孕药与癌症。证据综述。
Drug Saf. 1996 Apr;14(4):260-72. doi: 10.2165/00002018-199614040-00006.
本文引用的文献
1
Female hormone utilisation and risk of hepatocellular carcinoma.女性激素的使用与肝细胞癌风险
Br J Cancer. 1993 Mar;67(3):635-7. doi: 10.1038/bjc.1993.116.
2
Oral contraceptive use and mortality during 12 years of follow-up: the Nurses' Health Study.12年随访期间口服避孕药的使用与死亡率：护士健康研究
Ann Intern Med. 1994 May 15;120(10):821-6. doi: 10.7326/0003-4819-120-10-199405150-00002.
3
Trends in mortality from carcinoma of the liver and the use of oral contraceptives.肝癌死亡率趋势与口服避孕药的使用情况
Br J Cancer. 1983 Sep;48(3):349-54. doi: 10.1038/bjc.1983.199.
4
Hepatocellular carcinoma and oral contraceptives.肝细胞癌与口服避孕药
Br J Cancer. 1983 Sep;48(3):437-40. doi: 10.1038/bjc.1983.210.
5
Cancer of the liver and the use of oral contraceptives.肝癌与口服避孕药的使用
Br Med J (Clin Res Ed). 1986 May 24;292(6532):1357-61. doi: 10.1136/bmj.292.6532.1357.
6
Oral contraceptives and hepatocellular carcinoma.口服避孕药与肝细胞癌
Br Med J (Clin Res Ed). 1986 May 24;292(6532):1355-7. doi: 10.1136/bmj.292.6532.1355.
7
Oral contraceptives and primary liver cancer.口服避孕药与原发性肝癌
Br J Cancer. 1989 Mar;59(3):460-1. doi: 10.1038/bjc.1989.94.
8
The effects of oral contraceptives and parity on ovarian cancer trends in women under 55 years of age.口服避孕药和生育状况对55岁以下女性卵巢癌发病趋势的影响。
Br J Obstet Gynaecol. 1989 Jul;96(7):783-8. doi: 10.1111/j.1471-0528.1989.tb03316.x.
9
Oral contraceptive use and liver cancer.口服避孕药的使用与肝癌
Am J Epidemiol. 1989 Nov;130(5):878-82. doi: 10.1093/oxfordjournals.aje.a115420.
10
Risk factors for hepatocellular carcinoma in Catalonia, Spain.西班牙加泰罗尼亚地区肝细胞癌的风险因素。
Int J Cancer. 1990 Sep 15;46(3):378-81. doi: 10.1002/ijc.2910460307.
Zotero 插件